Cynata is a regenerative medicine company. Its Cymerus technology can produce vast quantities of Mesenchymal Stem Cells from a single blood donation. Cymerus is now in Phase 1 in acute Graft vs Host Disease. Japan’s Fujifilm has optioned this indication.
24/07/2017 The Swiss Army Knife of cellular remedie